Analysis of 6 meningiomas in patients with NF2 who were treated with everolimus for progressive vestibular schwannomas showed prolonged time to progression of the meningiomas from 5.5 months pretreatment to more than 12 months on therapy. The gene discussed is NF2; the disease is meningioma.